dynamiker

Dynamiker was founded in 2014 . It is committed to the R&D, production and global sales of innovative in vitro diagnostic products for invasive fungal diseases (IFD) and other pathogenic microorganisms. We have six core platforms, namely Ag/Ab preparation, molecular diagnostic, immunology, POCT, TAL (horseshoe crab) R&D and clinical transformation. Products are involved detection for panfungal screening, invasive aspergillosis, invasive candidiasis, cryptococcosis, mucomycosis, PJP, talaromyces marneffei., COVID-19 and bacterial resistance. All products are CE-IVD under ISO13485, More than 50 peer-reviewed papers and studies had proved the good quality of Dynamiker’s kits. Products have entered more than 500 key hospitals in more than 100 countries and regions in Asia, Europe, South America, Africa, and the Middle East by virtue of their strong competitive advantages.